#ACR19 – [Not Published Yet] Cohort Study: Half of People with Rheumatoid Arthritis Treated with Immune Checkpoint Inhibitors for Cancer Experience Flare, but Most Able to Continue Treatment
12 Nov, 2019 | 10:45h | UTCAbstract: Risk of Immunotherapy Related Toxicity in Patients with Rheumatoid Arthritis (free)
#ACR19 – Just Presented at the 2019 American College of Rheumatology Annual Meeting